Ubs Group Ag Bristol Myers Squibb CO Call Options Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $6.24 Million - $8.21 Million	-155,000 Reduced 51.42%	146,427 $6.08 Million
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $70.6 Million - $80.1 Million	-1,471,673 Reduced 83.0%	301,427 $16.3 Million
Q4 2023 Feb 09, 2024	BUY	$48.48 - $57.85 $8.49 Million - $10.1 Million	175,200 Added 10.96%	1,773,100 $91 Million
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $32.2 Million - $36 Million	556,500 Added 53.44%	1,597,900 $92.7 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $13.5 Million - $15 Million	-212,300 Reduced 16.93%	1,041,400 $66.6 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $1.01 Million - $1.14 Million	-15,300 Reduced 1.21%	1,253,700 $86.9 Million
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $49.4 Million - $58.5 Million	721,500 Added 131.78%	1,269,000 $91.3 Million
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $7,046 - $4.16 Million	54,200 Added 10.99%	547,500 $38.9 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $5.81 Million - $6.4 Million	80,000 Added 19.36%	493,300 $38 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $9.12 Million - $10.9 Million	148,300 Added 55.96%	413,300 $30.2 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $11.4 Million - $13.2 Million	211,834 Added 398.44%	265,000 $16.5 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $63.3 Million - $68.9 Million	-1,022,600 Reduced 95.06%	53,166 $3.55 Million
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $32.7 Million - $36.8 Million	550,966 Added 104.99%	1,075,766 $67.9 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $5.83 Million - $6.6 Million	100,900 Added 23.8%	524,800 $32.6 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $5.96 Million - $6.61 Million	-103,800 Reduced 19.67%	423,900 $25.6 Million
Q2 2020 Jul 31, 2020	SELL	$54.82 - $64.09 $19 Million - $22.2 Million	-347,000 Reduced 39.67%	527,700 $31 Million
Q1 2020 May 01, 2020	BUY	$46.4 - $67.43 $13.6 Million - $19.7 Million	292,200 Added 50.16%	874,700 $48.8 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $4.38 Million - $5.72 Million	89,100 Added 18.06%	582,500 $37.4 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $2.72 Million - $3.23 Million	-63,700 Reduced 11.43%	493,400 $25 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $3.48 Million - $3.84 Million	-77,900 Reduced 12.27%	557,100 $25.3 Million
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $6.65 Million - $7.92 Million	-147,300 Reduced 18.83%	635,000 $30.3 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $36.3 Million - $47.1 Million	744,200 Added 1953.28%	782,300 $40.7 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $88,304 - $99,600	1,600 Added 4.38%	38,100 $2.37 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $76.9 Million - $95.8 Million	-1,521,800 Reduced 97.66%	36,500 $2.02 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $80 Million - $92.1 Million	1,335,400 Added 599.1%	1,558,300 $98.6 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $1.23 Million - $1.34 Million	-20,500 Reduced 8.42%	222,900 $13.7 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $13.3 Million - $15.4 Million	241,630 Added 13651.41%	243,400 $15.5 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-4,013,080 Reduced 99.96%	1,770 $99,000
Q1 2017 Nov 14, 2017	BUY	N/A	4,014,850	4,014,850 $218 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account